COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 423: Articles 4221-4230  | Next

Inclusion of glycopeptides in hydrogen/deuterium exchange mass spectrometry analysis of SARS-CoV-2 spike ectodomain provides increased sequence coverage
Haynes, C. A., Keppel, T. R., Mekonnen, B., Osman, S. H., Zhou, Y., Woolfitt, A. R., Baudys, J., Barr, J. R., Wang, D.
10.1101/2023.06.14.544985 — Posted: 2023-06-15
Defining the single base importance of human mRNAs and lncRNAs
Fan, R., Ji, X., Li, J., Cui, Q., Cui, C.
10.1101/2023.06.12.544536 — Posted: 2023-06-15
Evaluation and Treatment of Severe SARS-CoV-2 Pneumonia: A Scoping Review
Li, X., Huang, J.
10.1101/2023.06.13.23291341 — Posted: 2023-06-14
Partially hydrolyzed guar gum attenuates the symptoms of SARS-CoV-2 infection through gut microbiota modulation in an animal model.
Yang, J., Song, I., Saito, M., Hartanto, T., Ichinohe, T., Fukuda, S.
10.1101/2023.06.13.544519 — Posted: 2023-06-14
Biophysical evolution of the receptor binding domains of SARS-CoVs
Upadhyay, V., Panja, S., Lucas, A., Patrick, C., Mallela, K.
10.1101/2023.06.13.544630 — Posted: 2023-06-14
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
Trepte, P., Secker, C., Kostova, S., Maseko, S. B., Choi, S. G., Blavier, J., Minia, I., Silva Ramos, E., Cassonnet, P., Golusik, S., Zenkner, M., Beetz, S., Liebich, M. J., Scharek, N., Schuetz, A., Sperling, M., Lisurek, M., Wang, Y., Spirohn, K., Hao, T., Calderwood, M. A., Hill, D. E., Landthaler, M., Olivet, J., Twizere, J.-C., Vidal, M., Wanker, E. E.
10.1101/2023.06.14.544560 — Posted: 2023-06-14
Mycobiome analyses of critically ill COVID-19 patients suggests antifungal prophylaxis may be protective against A. fumigatus-associated mortality
Weaver, D., Gago, S., Bassetti, M., Giacobbe, D. R., Prattes, J., Hoenigl, M., Reizine, F., Guegan, H., Gangneux, J.-P., Bromley, M. J., Bowyer, P.
10.1101/2023.06.13.543274 — Posted: 2023-06-13
SARS CoV-2 Envelope protein alters calcium signaling via SERCA interactions
Berta, B., Tordai, H., Lukacs, G. L., Papp, B., Enyedi, A., Padanyi, R., Hegedus, T.
10.1101/2023.06.13.544745 — Posted: 2023-06-13
C1q Enables Influenza HA Stem Binding Antibodies to Block Viral Attachment and Broadens the Antibody Escape Repertoire
Kosik, I., Santos, J. D. S., Angel, M., Hu, Z., Holly, J., Gibbs, J. S., Gill, T. U., Kosikova, M., Li, T., Bakhache, W., Dolan, P. T., Xie, H., Andrews, S. F., Gillespie, R. A., Kanekiyo, M., McDermott, A. B., Pierson, T. C., yewdell, j.
10.1101/2023.06.12.544648 — Posted: 2023-06-13
Polygenic risk of idiopathic pulmonary fibrosis and COVID-19 severity
Guillen-Guio, B., Marcelino-Rodriguez, I., Lorenzo-Salazar, J. M., Leavy, O. C., Allen, R. J., Scourge Cohort Group, , Riancho, J. A., Rojas, A., Lapunzina, P., Carracedo, A., Wain, L. V., Flores, C.
10.1101/2023.06.12.23291269 — Posted: 2023-06-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).